| Resolution Plan - Reduction of Share Capital & suspension of trading in equity shares of Sharon Bio-Medicine Ltd. (Scrip Code: 532908) |
Trading members of the Exchange are hereby informed that, Sharon Bio-Medicine Ltd. has fixed the Record Date for the purpose of suspension of trading due to reduction of Share Capital of the company as per the resolution plan approved by the Hon’ble National Company Law Tribunal (NCLT) at Mumbai.
|
COMPANY NAME &
CODE
|
RECORD DATE
|
PURPOSE
|
NO DEALINGS FROM
DATE &
SETT. NO.
|
|
Sharon Bio-Medicine Ltd. (532908)
|
02/04/2019
|
As per the Resolution Plan approved by Hon’ble NCLT, Mumbai Bench vide order dated February 28,2018 and November 12,2018 under provision of Insolvency & Bankruptcy Code 2013
Reduction of Share Capital:
The company is undertaking a selective capital reduction of i) the entire shareholding held by the [erstwhile] promoter group & secured lenders of the company;
ii) up to 90% of the equity shares held by public shareholders.
|
29/03/2019
DR- 002/2019-2020
|
Trading Members of the Exchange are requested to take note of it.
Mangesh Tayde
Senior Manager –Listing Operations (CRD)
March 19, 2019
|